+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Drug Discovery Informatics Market - Global Forecast to 2030- Product Image
Drug Discovery Informatics Market - Global Forecast to 2030- Product Image
Sale

Drug Discovery Informatics Market - Global Forecast to 2030

  • PDF Icon

    Report

  • 191 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5887835
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Drug Discovery Informatics Market grew from USD 3.19 billion in 2024 to USD 3.51 billion in 2025. It is expected to continue growing at a CAGR of 9.95%, reaching USD 5.64 billion by 2030.

The landscape of drug discovery informatics is undergoing a profound transformation, driven by the convergence of advanced computational methods, high-throughput data generation and the imperative for cost-effective innovation. As novel therapeutic modalities emerge and the complexity of biological targets deepens, informatics platforms have become indispensable for streamlining candidate identification, accelerating preclinical testing and optimizing translational pathways. This executive summary provides a concise yet comprehensive overview of the critical forces shaping the sector, from regulatory policy shifts to the evolving needs of end users. By examining both the technological underpinnings and the strategic market drivers, decision-makers will gain insight into how informatics solutions can deliver competitive advantage. The following sections explore the macroeconomic headwinds, segmentation breakdowns, regional dynamics and key industry players, culminating in actionable recommendations to guide investment and operational strategies.

Transformative Innovations Reshaping the Informatics Landscape

Over the past decade, drug discovery informatics has shifted from isolated data analysis toward integrated, AI-powered platforms that support end-to-end workflows. Machine learning models now predict drug interactions and toxicology profiles with increasing accuracy, replacing manual curation in early‐stage screening. Concurrently, blockchain protocols are being evaluated for ensuring data integrity across multi‐institutional consortia. Internet-of-things integration in lab automation has enabled real-time monitoring of experimental variables, reducing variability and accelerating reproducibility. Organizations that once relied solely on custom informatics solutions are now embracing modular software suites capable of molecular modeling, structure-activity relationship analysis and virtual screening. Consulting services have evolved to include strategic advisory on informatics architecture, while data management offerings ensure compliance with stringent data governance standards. This transformation is redefining competitive benchmarks, as agile, cloud-enabled platforms challenge traditional on-premises deployments and reshape the path from target validation to candidate progression.

Cumulative Effects of 2025 U.S. Tariffs on Procurement Dynamics

In 2025, cumulative tariffs imposed by the United States on critical imports have introduced new variables into the cost structures of informatics hardware and software procurement. Servers and workstations acquired for high-performance computing now carry incremental duties, leading organizations to reassess on-premises investments and reallocate budgets toward cloud-based solutions that sidestep hardware import levies. Software licensing agreements, especially those originating from overseas vendors, have seen adjustments in total cost of ownership as duties are passed through by resellers. Service providers with international delivery models face margin pressure, prompting renegotiations of consulting contracts and data management fees. This scenario has accelerated adoption of domestically hosted deployments and incentivized partnerships with local hardware manufacturers. As a result, the tariff environment has acted as an unexpected catalyst for cloud migration and supply-chain localization within informatics ecosystems.

Deep Dive into Market Segmentation and Technology Layers

When evaluating product portfolios, service segments encompass consulting services for workflow optimization, custom informatics solutions tailored to specific therapeutic areas and comprehensive data management that ensures compliance with evolving regulations. In parallel, software solutions span molecular modeling for structural elucidation, structure-activity relationship tools that correlate chemical modifications with biological outcomes and virtual screening platforms powered by AI algorithms. End users range from academic research institutions-both government research bodies and university laboratories-to biotechnology companies structured around genomics research teams and proteomics research teams; contract research organizations organized under CRO management and data analysis teams; and pharmaceutical companies supported by clinical research organizations and dedicated drug development teams. Application domains include genomics with DNA analysis and genomic sequencing, molecular modeling through 3D structure analysis and fragment-based design, preclinical testing via ADME-Tox studies and in silico models, and transcriptomics encompassing expression profiling and RNA sequencing. Component analysis highlights hardware offerings such as servers and workstations alongside software and services that cover both implementation and ongoing maintenance. Deployment options bifurcate into cloud-based environments for scalable compute capacity and on-premises installations for sensitive data control. Finally, emerging technologies like blockchain for data integrity assurance, IoT integration for automated laboratory workflows and machine learning modules for drug interaction prediction and predictive modeling complete the technology stack.

Regional Dynamics Influencing Adoption Patterns

Across the Americas, a mature ecosystem of leading informatics providers coexists with a robust network of academic centers and contract research services, driving rapid adoption of AI-enhanced platforms. In Europe, Middle East & Africa, regulatory harmonization initiatives and pan-regional consortia facilitate collaborative data sharing, while specialty markets in the Middle East invest heavily in infrastructure to support precision medicine research. The Asia-Pacific region demonstrates explosive growth in demand for cloud-native informatics solutions, propelled by government-backed genomics initiatives in countries like China, India and Australia. Regional academic and industrial partnerships are fostering co-development models, particularly in molecular modeling and transcriptomics. Cultural emphasis on innovation ecosystems in these markets is accelerating commercialization pathways, as local vendors adapt global platforms to meet regional compliance requirements. This geographic mosaic underscores the importance of tailored strategies that address distinct regulatory environments, infrastructure maturity levels and stakeholder expectations.

Profiles of Leading Innovators Driving Market Evolution

Industry leaders are increasingly differentiated by their ability to integrate cross-disciplinary expertise, exemplified by organizations such as Accenture PLC, which leverages consulting heritage to deliver end-to-end informatics transformations. Agilent Technologies, Inc. continues to expand laboratory automation offerings that synergize hardware with data management services, while Aragen Life Sciences Ltd. provides custom informatics pipelines for complex biologics research. Boehringer Ingelheim International GmbH drives internal platform innovation, complementing external collaborations. Cadence Design Systems, Inc. and Dassault Systèmes SE extend their electronic design automation expertise into molecular modeling arenas. Certara, Inc. and Collaborative Drug Discovery, Inc. focus on translational modeling and collaborative research networks, respectively. Companies such as Charles River Laboratories International, Inc. and Crown Bioscience, Inc. couple preclinical capabilities with in silico testing modules. ChemAxon Ltd. and Schrödinger, Inc. are renowned for cheminformatics solutions, while Cognizant Technology Solutions Corporation and Infosys Limited deliver scalable software integration services. Eurofins DiscoverX Products LLC and PerkinElmer Inc. offer specialized assay platforms integrated with informatics workflows. Evotec AG and InSilico Medicine blend biotech R&D with AI-driven predictive modeling. Illumina, Inc. powers genomics workflows, and International Business Machines Corporation contributes enterprise-grade cloud and blockchain solutions. Jubilant Biosys Ltd. and WuXi AppTec Co., Ltd. provide contract research informatics, while Oracle Corporation, Thermo Fisher Scientific Inc. and Selvita S.A. continue to expand their portfolios across software, hardware and services.

Strategic Actions to Strengthen Informatics Capabilities

Leaders should prioritize integration of machine learning models into existing informatics architectures, ensuring real-time predictive analytics guide early‐stage decision making. Establishing strategic alliances with domestic hardware manufacturers can mitigate tariff impact and secure supply-chain resilience. Deploying hybrid infrastructure that balances cloud scalability with on-premises security controls will optimize both cost and compliance. Investment in modular software frameworks enables rapid customization for diverse end-users, from academic research bodies to pharmaceutical development teams. Furthermore, formalizing data governance protocols through blockchain pilots will enhance transparency across multi-site collaborations. To sustain competitive advantage, organizations must continuously upskill internal teams on AI and IoT tool deployments while forging partnerships that extend capabilities into emerging application areas such as transcriptomics and ADME-Tox modeling.

Concluding Perspectives on Informatics as a Competitive Differentiator

The convergence of advanced computation, regulatory complexity and global economic pressures has elevated informatics from a support function to a strategic enabler of drug discovery. Organizations that embrace modular, AI-powered platforms, cultivate diversified deployment strategies and form collaborative ecosystems will outpace peers in both innovation throughput and operational efficiency. By aligning technology roadmaps with evolving end-user needs and regional compliance landscapes, decision-makers can transform informatics investments into tangible advances in therapeutic development.

Market Segmentation & Coverage

This research report categorizes the Drug Discovery Informatics Market to forecast the revenues and analyze trends in each of the following sub-segmentations:

  • Services
    • Consulting Services
    • Custom Informatics Solutions
    • Data Management
  • Software Solutions
    • Molecular Modeling
    • Structure-Activity Relationships Tools
    • Virtual Screening Tools
  • Academic Research Institutions
    • Government Research Bodies
    • University Research Labs
  • Biotechnology Companies
    • Genomics Research Teams
    • Proteomics Research Teams
  • Contract Research Organizations
    • CRO Management Teams
    • Data Analysis Teams
  • Pharmaceutical Companies
    • Clinical Research Organizations
    • Drug Development Teams
  • Genomics
    • DNA Analysis
    • Genomic Sequencing
  • Molecular Modeling
    • 3D Structure Analysis
    • Fragment-Based Design
  • Preclinical Testing
    • ADME-Tox Studies
    • In Silico Study Models
  • Transcriptomics
    • Expression Profiling
    • RNA Sequencing
  • Hardware
    • Servers
    • Workstations
  • Services
    • Implementation Services
    • Maintenance Services
  • Software
  • Cloud-Based
  • On-Premises
  • Blockchain
    • Data Integrity Assurance
  • IoT Integration
  • Machine Learning
    • Drug Interaction Prediction
    • Predictive Modeling

This research report categorizes the Drug Discovery Informatics Market to forecast the revenues and analyze trends in each of the following sub-regions:

  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

This research report categorizes the Drug Discovery Informatics Market to delves into recent significant developments and analyze trends in each of the following companies:

  • Accenture PLC
  • Agilent Technologies, Inc.
  • Aragen Life Sciences Ltd.
  • Boehringer Ingelheim International GmbH
  • Cadence Design Systems, Inc.
  • Certara, Inc.
  • Charles River Laboratories International, Inc.
  • ChemAxon Ltd.
  • Cognizant Technology Solutions Corporation
  • Collaborative Drug Discovery, Inc
  • Crown Bioscience, Inc.
  • Dassault Systèmes SE
  • Eurofins DiscoverX Products LLC
  • Evotec AG
  • Illumina, Inc.
  • Infosys Limited
  • InSilico Medicine
  • International Business Machines Corporation
  • Jubilant Biosys Ltd.
  • Oracle Corporation
  • PerkinElmer Inc.
  • Schrödinger, Inc.
  • Selvita S.A.
  • Thermo Fisher Scientific Inc.
  • WuXi AppTec Co., Ltd.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Drug Discovery Informatics Market, by Product Type
8.1. Introduction
8.2. Services
8.2.1. Consulting Services
8.2.2. Custom Informatics Solutions
8.2.3. Data Management
8.3. Software Solutions
8.3.1. Molecular Modeling
8.3.2. Structure-Activity Relationships Tools
8.3.3. Virtual Screening Tools
9. Drug Discovery Informatics Market, by End User
9.1. Introduction
9.2. Academic Research Institutions
9.2.1. Government Research Bodies
9.2.2. University Research Labs
9.3. Biotechnology Companies
9.3.1. Genomics Research Teams
9.3.2. Proteomics Research Teams
9.4. Contract Research Organizations
9.4.1. CRO Management Teams
9.4.2. Data Analysis Teams
9.5. Pharmaceutical Companies
9.5.1. Clinical Research Organizations
9.5.2. Drug Development Teams
10. Drug Discovery Informatics Market, by Application
10.1. Introduction
10.2. Genomics
10.2.1. DNA Analysis
10.2.2. Genomic Sequencing
10.3. Molecular Modeling
10.3.1. 3D Structure Analysis
10.3.2. Fragment-Based Design
10.4. Preclinical Testing
10.4.1. ADME-Tox Studies
10.4.2. In Silico Study Models
10.5. Transcriptomics
10.5.1. Expression Profiling
10.5.2. RNA Sequencing
11. Drug Discovery Informatics Market, by Component
11.1. Introduction
11.2. Hardware
11.2.1. Servers
11.2.2. Workstations
11.3. Services
11.3.1. Implementation Services
11.3.2. Maintenance Services
11.4. Software
12. Drug Discovery Informatics Market, by Deployment Mode
12.1. Introduction
12.2. Cloud-Based
12.3. On-Premises
13. Drug Discovery Informatics Market, by Technology
13.1. Introduction
13.2. Blockchain
13.2.1. Data Integrity Assurance
13.3. IoT Integration
13.4. Machine Learning
13.4.1. Drug Interaction Prediction
13.4.2. Predictive Modeling
14. Americas Drug Discovery Informatics Market
14.1. Introduction
14.2. Argentina
14.3. Brazil
14.4. Canada
14.5. Mexico
14.6. United States
15. Asia-Pacific Drug Discovery Informatics Market
15.1. Introduction
15.2. Australia
15.3. China
15.4. India
15.5. Indonesia
15.6. Japan
15.7. Malaysia
15.8. Philippines
15.9. Singapore
15.10. South Korea
15.11. Taiwan
15.12. Thailand
15.13. Vietnam
16. Europe, Middle East & Africa Drug Discovery Informatics Market
16.1. Introduction
16.2. Denmark
16.3. Egypt
16.4. Finland
16.5. France
16.6. Germany
16.7. Israel
16.8. Italy
16.9. Netherlands
16.10. Nigeria
16.11. Norway
16.12. Poland
16.13. Qatar
16.14. Russia
16.15. Saudi Arabia
16.16. South Africa
16.17. Spain
16.18. Sweden
16.19. Switzerland
16.20. Turkey
16.21. United Arab Emirates
16.22. United Kingdom
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Accenture PLC
17.3.2. Agilent Technologies, Inc.
17.3.3. Aragen Life Sciences Ltd.
17.3.4. Boehringer Ingelheim International GmbH
17.3.5. Cadence Design Systems, Inc.
17.3.6. Certara, Inc.
17.3.7. Charles River Laboratories International, Inc.
17.3.8. ChemAxon Ltd.
17.3.9. Cognizant Technology Solutions Corporation
17.3.10. Collaborative Drug Discovery, Inc
17.3.11. Crown Bioscience, Inc.
17.3.12. Dassault Systèmes SE
17.3.13. Eurofins DiscoverX Products LLC
17.3.14. Evotec AG
17.3.15. Illumina, Inc.
17.3.16. Infosys Limited
17.3.17. InSilico Medicine
17.3.18. International Business Machines Corporation
17.3.19. Jubilant Biosys Ltd.
17.3.20. Oracle Corporation
17.3.21. PerkinElmer Inc.
17.3.22. Schrödinger, Inc.
17.3.23. Selvita S.A.
17.3.24. Thermo Fisher Scientific Inc.
17.3.25. WuXi AppTec Co., Ltd.
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. DRUG DISCOVERY INFORMATICS MARKET MULTI-CURRENCY
FIGURE 2. DRUG DISCOVERY INFORMATICS MARKET MULTI-LANGUAGE
FIGURE 3. DRUG DISCOVERY INFORMATICS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY COMPONENT, 2024 VS 2030 (%)
FIGURE 14. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY COMPONENT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DEPLOYMENT MODE, 2024 VS 2030 (%)
FIGURE 16. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DEPLOYMENT MODE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 18. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS DRUG DISCOVERY INFORMATICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS DRUG DISCOVERY INFORMATICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES DRUG DISCOVERY INFORMATICS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES DRUG DISCOVERY INFORMATICS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC DRUG DISCOVERY INFORMATICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC DRUG DISCOVERY INFORMATICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. DRUG DISCOVERY INFORMATICS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. DRUG DISCOVERY INFORMATICS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. DRUG DISCOVERY INFORMATICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY CONSULTING SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY CUSTOM INFORMATICS SOLUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DATA MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOFTWARE SOLUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY MOLECULAR MODELING, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY STRUCTURE-ACTIVITY RELATIONSHIPS TOOLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY VIRTUAL SCREENING TOOLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOFTWARE SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY GOVERNMENT RESEARCH BODIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY UNIVERSITY RESEARCH LABS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY GENOMICS RESEARCH TEAMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY PROTEOMICS RESEARCH TEAMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY CRO MANAGEMENT TEAMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DATA ANALYSIS TEAMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY CLINICAL RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT TEAMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY GENOMICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DNA ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY GENOMIC SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY MOLECULAR MODELING, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY 3D STRUCTURE ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FRAGMENT-BASED DESIGN, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY MOLECULAR MODELING, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY PRECLINICAL TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY ADME-TOX STUDIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY IN SILICO STUDY MODELS, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY PRECLINICAL TESTING, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY TRANSCRIPTOMICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY EXPRESSION PROFILING, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY RNA SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY HARDWARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SERVERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY WORKSTATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY IMPLEMENTATION SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY MAINTENANCE SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY CLOUD-BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY ON-PREMISES, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY BLOCKCHAIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DATA INTEGRITY ASSURANCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY BLOCKCHAIN, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY IOT INTEGRATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 69. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY MACHINE LEARNING, BY REGION, 2018-2030 (USD MILLION)
TABLE 70. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG INTERACTION PREDICTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 71. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY PREDICTIVE MODELING, BY REGION, 2018-2030 (USD MILLION)
TABLE 72. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY MACHINE LEARNING, 2018-2030 (USD MILLION)
TABLE 73. AMERICAS DRUG DISCOVERY INFORMATICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 74. AMERICAS DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 75. AMERICAS DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOFTWARE SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 76. AMERICAS DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 77. AMERICAS DRUG DISCOVERY INFORMATICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 78. AMERICAS DRUG DISCOVERY INFORMATICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 79. AMERICAS DRUG DISCOVERY INFORMATICS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 80. AMERICAS DRUG DISCOVERY INFORMATICS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 81. AMERICAS DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 82. AMERICAS DRUG DISCOVERY INFORMATICS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
TABLE 83. AMERICAS DRUG DISCOVERY INFORMATICS MARKET SIZE, BY MOLECULAR MODELING, 2018-2030 (USD MILLION)
TABLE 84. AMERICAS DRUG DISCOVERY INFORMATICS MARKET SIZE, BY PRECLINICAL TESTING, 2018-2030 (USD MILLION)
TABLE 85. AMERICAS DRUG DISCOVERY INFORMATICS MARKET SIZE, BY TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
TABLE 86. AMERICAS DRUG DISCOVERY INFORMATICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 87. AMERICAS DRUG DISCOVERY INFORMATICS MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
TABLE 88. AMERICAS DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 89. AMERICAS DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
TABLE 90. AMERICAS DRUG DISCOVERY INFORMATICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 91. AMERICAS DRUG DISCOVERY INFORMATICS MARKET SIZE, BY BLOCKCHAIN, 2018-2030 (USD MILLION)
TABLE 92. AMERICAS DRUG DISCOVERY INFORMATICS MARKET SIZE, BY MACHINE LEARNING, 2018-2030 (USD MILLION)
TABLE 93. AMERICAS DRUG DISCOVERY INFORMATICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 94. ARGENTINA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 95. ARGENTINA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 96. ARGENTINA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOFTWARE SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 97. ARGENTINA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 98. ARGENTINA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 99. ARGENTINA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 100. ARGENTINA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 101. ARGENTINA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 102. ARGENTINA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 103. ARGENTINA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
TABLE 104. ARGENTINA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY MOLECULAR MODELING, 2018-2030 (USD MILLION)
TABLE 105. ARGENTINA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY PRECLINICAL TESTING, 2018-2030 (USD MILLION)
TABLE 106. ARGENTINA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
TABLE 107. ARGENTINA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 108. ARGENTINA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
TABLE 109. ARGENTINA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 110. ARGENTINA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
TABLE 111. ARGENTINA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 112. ARGENTINA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY BLOCKCHAIN, 2018-2030 (USD MILLION)
TABLE 113. ARGENTINA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY MACHINE LEARNING, 2018-2030 (USD MILLION)
TABLE 114. BRAZIL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 115. BRAZIL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 116. BRAZIL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOFTWARE SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 117. BRAZIL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 118. BRAZIL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 119. BRAZIL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 120. BRAZIL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 121. BRAZIL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 122. BRAZIL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 123. BRAZIL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
TABLE 124. BRAZIL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY MOLECULAR MODELING, 2018-2030 (USD MILLION)
TABLE 125. BRAZIL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY PRECLINICAL TESTING, 2018-2030 (USD MILLION)
TABLE 126. BRAZIL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
TABLE 127. BRAZIL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 128. BRAZIL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
TABLE 129. BRAZIL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 130. BRAZIL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
TABLE 131. BRAZIL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 132. BRAZIL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY BLOCKCHAIN, 2018-2030 (USD MILLION)
TABLE 133. BRAZIL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY MACHINE LEARNING, 2018-2030 (USD MILLION)
TABLE 134. CANADA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 135. CANADA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 136. CANADA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOFTWARE SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 137. CANADA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 138. CANADA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 139. CANADA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 140. CANADA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 141. CANADA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 142. CANADA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 143. CANADA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
TABLE 144. CANADA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY MOLECULAR MODELING, 2018-2030 (USD MILLION)
TABLE 145. CANADA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY PRECLINICAL TESTING, 2018-2030 (USD MILLION)
TABLE 146. CANADA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
TABLE 147. CANADA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 148. CANADA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
TABLE 149. CANADA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 150. CANADA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
TABLE 151. CANADA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 152. CANADA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY BLOCKCHAIN, 2018-2030 (USD MILLION)
TABLE 153. CANADA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY MACHINE LEARNING, 2018-2030 (USD MILLION)
TABLE 154. MEXICO DRUG DISCOVERY INFORMATICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 155. MEXICO DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 156. MEXICO DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOFTWARE SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 157. MEXICO DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 158. MEXICO DRUG DISCOVERY INFORMATICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 159. MEXICO DRUG DISCOVERY INFORMATICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 160. MEXICO DRUG DISCOVERY INFORMATICS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 161. MEXICO DRUG DISCOVERY INFORMATICS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 162. MEXICO DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 163. MEXICO DRUG DISCOVERY INFORMATICS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
TABLE 164. MEXICO DRUG DISCOVERY INFORMATICS MARKET SIZE, BY MOLECULAR MODELING, 2018-2030 (USD MILLION)
TABLE 165. MEXICO DRUG DISCOVERY INFORMATICS MARKET SIZE, BY PRECLINICAL TESTING, 2018-2030 (USD MILLION)
TABLE 166. MEXICO DRUG DISCOVERY INFORMATICS MARKET SIZE, BY TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
TABLE 167. MEXICO DRUG DISCOVERY INFORMATICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 168. MEXICO DRUG DISCOVERY INFORMATICS MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
TABLE 169. MEXICO DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 170. MEXICO DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
TABLE 171. MEXICO DRUG DISCOVERY INFORMATICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 172. MEXICO DRUG DISCOVERY INFORMATICS MARKET SIZE, BY BLOCKCHAIN, 2018-2030 (USD MILLION)
TABLE 173. MEXICO DRUG DISCOVERY INFORMATICS MARKET SIZE, BY MACHINE LEARNING, 2018-2030 (USD MILLION)
TABLE 174. UNITED STATES DRUG DISCOVERY INFORMATICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 175. UNITED STATES DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 176. UNITED STATES DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOFTWARE SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 177. UNITED STATES DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 178. UNITED STATES DRUG DISCOVERY INFORMATICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 179. UNITED STATES DRUG DISCOVERY INFORMATICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 180. UNITED STATES DRUG DISCOVERY INFORMATICS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 181. UNITED STATES DRUG DISCOVERY INFORMATICS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 182. UNITED STATES DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 183. UNITED STATES DRUG DISCOVERY INFORMATICS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
TABLE 184. UNITED STATES DRUG DISCOVERY INFORMATICS MARKET SIZE, BY MOLECULAR MODELING, 2018-2030 (USD MILLION)
TABLE 185. UNITED STATES DRUG DISCOVERY INFORMATICS MARKET SIZE, BY PRECLINICAL TESTING, 2018-2030 (USD MILLION)
TABLE 186. UNITED STATES DRUG DISCOVERY INFORMATICS MARKET SIZE, BY TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
TABLE 187. UNITED STATES DRUG DISCOVERY INFORMATICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 188. UNITED STATES DRUG DISCOVERY INFORMATICS MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
TABLE 189. UNITED STATES DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 190. UNITED STATES DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
TABLE 191. UNITED STATES DRUG DISCOVERY INFORMATICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 192. UNITED STATES DRUG DISCOVERY INFORMATICS MARKET SIZE, BY BLOCKCHAIN, 2018-2030 (USD MILLION)
TABLE 193. UNITED STATES DRUG DISCOVERY INFORMATICS MARKET SIZE, BY MACHINE LEARNING, 2018-2030 (USD MILLION)
TABLE 194. UNITED STATES DRUG DISCOVERY INFORMATICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 195. ASIA-PACIFIC DRUG DISCOVERY INFORMATICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 196. ASIA-PACIFIC DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 197. ASIA-PACIFIC DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOFTWARE SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 198. ASIA-PACIFIC DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 199. ASIA-PACIFIC DRUG DISCOVERY INFORMATICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 200. ASIA-PACIFIC DRUG DISCOVERY INFORMATICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 201. ASIA-PACIFIC DRUG DISCOVERY INFORMATICS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 202. ASIA-PACIFIC DRUG DISCOVERY INFORMATICS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 203. ASIA-PACIFIC DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 204. ASIA-PACIFIC DRUG DISCOVERY INFORMATICS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
TABLE 205. ASIA-PACIFIC DRUG DISCOVERY INFORMATICS MARKET SIZE, BY MOLECULAR MODELING, 2018-2030 (USD MILLION)
TABLE 206. ASIA-PACIFIC DRUG DISCOVERY INFORMATICS MARKET SIZE, BY PRECLINICAL TESTING, 2018-2030 (USD MILLION)
TABLE 207. ASIA-PACIFIC DRUG DISCOVERY INFORMATICS MARKET SIZE, BY TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
TABLE 208. ASIA-PACIFIC DRUG DISCOVERY INFORMATICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 209. ASIA-PACIFIC DRUG DISCOVERY INFORMATICS MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
TABLE 210. ASIA-PACIFIC DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 211. ASIA-PACIFIC DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
TABLE 212. ASIA-PACIFIC DRUG DISCOVERY INFORMATICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 213. ASIA-PACIFIC DRUG DISCOVERY INFORMATICS MARKET SIZE, BY BLOCKCHAIN, 2018-2030 (USD MILLION)
TABLE 214. ASIA-PACIFIC DRUG DISCOVERY INFORMATICS MARKET SIZE, BY MACHINE LEARNING, 2018-2030 (USD MILLION)
TABLE 215. ASIA-PACIFIC DRUG DISCOVERY INFORMATICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 216. AUSTRALIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 217. AUSTRALIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 218. AUSTRALIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOFTWARE SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 219. AUSTRALIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 220. AUSTRALIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 221. AUSTRALIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 222. AUSTRALIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 223. AUSTRALIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 224. AUSTRALIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 225. AUSTRALIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
TABLE 226. AUSTRALIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY MOLECULAR MODELING, 2018-2030 (USD MILLION)
TABLE 227. AUSTRALIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY PRECLINICAL TESTING, 2018-2030 (USD MILLION)
TABLE 228. AUSTRALIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
TABLE 229. AUSTRALIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 230. AUSTRALIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
TABLE 231. AUSTRALIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 232. AUSTRALIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
TABLE 233. AUSTRALIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 234. AUSTRALIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY BLOCKCHAIN, 2018-2030 (USD MILLION)
TABLE 235. AUSTRALIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY MACHINE LEARNING, 2018-2030 (USD MILLION)
TABLE 236. CHINA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 237. CHINA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 238. CHINA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOFTWARE SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 239. CHINA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 240. CHINA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 241. CHINA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 242. CHINA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 243. CHINA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 244. CHINA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 245. CHINA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
TABLE 246. CHINA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY MOLECULAR MODELING, 2018-2030 (USD MILLION)
TABLE 247. CHINA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY PRECLINICAL TESTING, 2018-2030 (USD MILLION)
TABLE 248. CHINA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
TABLE 249. CHINA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 250. CHINA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
TABLE 251. CHINA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 252. CHINA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
TABLE 253. CHINA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 254. CHINA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY BLOCKCHAIN, 2018-2030 (USD MILLION)
TABLE 255. CHINA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY MACHINE LEARNING, 2018-2030 (USD MILLION)
TABLE 256. INDIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 257. INDIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 258. INDIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOFTWARE SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 259. INDIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 260. INDIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 261. INDIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 262. INDIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 263. INDIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 264. INDIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 265. INDIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
TABLE 266. INDIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY MOLECULAR MODELING, 2018-2030 (USD MILLION)
TABLE 267. INDIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY PRECLINICAL TESTING, 2018-2030 (USD MILLION)
TABLE 268. INDIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
TABLE 269. INDIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 270. INDIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
TABLE 271. INDIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 272. INDIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
TABLE 273. INDIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 274. INDIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY BLOCKCHAIN, 2018-2030 (USD MILLION)
TABLE 275. INDIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY MACHINE LEARNING, 2018-2030 (USD MILLION)
TABLE 276. INDONESIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 277. INDONESIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 278. INDONESIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOFTWARE SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 279. INDONESIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 280. INDONESIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 281. INDONESIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 282. INDONESIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 283. INDONESIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 284. INDONESIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 285. INDONESIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
TABLE 286. INDONESIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY MOLECULAR MODELING, 2018-2030 (USD MILLION)
TABLE 287. INDONESIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY PRECLINICAL TESTING, 2018-2030 (USD MILLION)
TABLE 288. INDONESIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
TABLE 289. INDONESIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 290. INDONESIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
TABLE 291. INDONESIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 292. INDONESIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
TABLE 293. INDONESIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 294. INDONESIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY BLOCKCHAIN, 2018-2030 (USD MILLION)
TABLE 295. INDONESIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY MACHINE LEARNING, 2018-2030 (USD MILLION)
TABLE 296. JAPAN DRUG DISCOVERY INFORMATICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 297. JAPAN DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 298. JAPAN DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOFTWARE SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 299. JAPAN DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 300. JAPAN DRUG DISCOVERY INFORMATICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 301. JAPAN DRUG DISCOVERY INFORMATICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 302. JAPAN DRUG DISCOVERY INFORMATICS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 303. JAPAN DRUG DISCOVERY INFORMATICS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 304. JAPAN DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 305. JAPAN DRUG DISCOVERY INFORMATICS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
TABLE 306. JAPAN DRUG DISCOVERY INFORMATICS MARKET SIZE, BY MOLECULAR MODELING, 2018-2030 (USD MILLION)
TABLE 307. JAPAN DRUG DISCOVERY INFORMATICS MARKET SIZE, BY PRECLINICAL TESTING, 2018-2030 (USD MILLION)
TABLE 308. JAPAN DRUG DISCOVERY INFORMATICS MARKET SIZE, BY TRANSCRIPTOMICS, 2018-2030 (USD MILLION)
TABLE 309. JAPAN DRUG DISCOVERY INFORMATICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 310. JAPAN DRUG DISCOVERY INFORMATICS MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
TABLE 311. JAPAN DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 312. JAPAN DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
TABLE 313. JAPAN DRUG DISCOVER

Companies Mentioned

  • Accenture PLC
  • Agilent Technologies, Inc.
  • Aragen Life Sciences Ltd.
  • Boehringer Ingelheim International GmbH
  • Cadence Design Systems, Inc.
  • Certara, Inc.
  • Charles River Laboratories International, Inc.
  • ChemAxon Ltd.
  • Cognizant Technology Solutions Corporation
  • Collaborative Drug Discovery, Inc
  • Crown Bioscience, Inc.
  • Dassault Systèmes SE
  • Eurofins DiscoverX Products LLC
  • Evotec AG
  • Illumina, Inc.
  • Infosys Limited
  • InSilico Medicine
  • International Business Machines Corporation
  • Jubilant Biosys Ltd.
  • Oracle Corporation
  • PerkinElmer Inc.
  • Schrödinger, Inc.
  • Selvita S.A.
  • Thermo Fisher Scientific Inc.
  • WuXi AppTec Co., Ltd.

Methodology

Loading
LOADING...

Related Topics

Related Reports

Drug Discovery Informatics Market Size, Share & Trends Analysis Report By Service (Molecular Modelling), By Application (Discovery Informatics), By End-use (Academic & Research Institutes), By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Drug Discovery Informatics Market Size, Share & Trends Analysis Report By Service (Molecular Modelling), By Application (Discovery Informatics), By End-use (Academic & Research Institutes), By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 110 Pages
  • Global
From
Drug Discovery Informatics Market Report by Workflow, and Region 2024-2032 - Product Image

Drug Discovery Informatics Market Report by Workflow, and Region 2024-2032

  • Report
  • 148 Pages
  • Global
From
Drug Discovery Informatics - Global Strategic Business Report - Product Image

Drug Discovery Informatics - Global Strategic Business Report

  • Report
  • 188 Pages
  • Global
From
Drug Discovery Informatics Market Innovations and Strategic Insights Report - Market Data, Trends, Market Potential, Competitive Analysis and Growth Forecasts (2024 to 2032) - Product Image

Drug Discovery Informatics Market Innovations and Strategic Insights Report - Market Data, Trends, Market Potential, Competitive Analysis and Growth Forecasts (2024 to 2032)

  • Report
  • 157 Pages
  • Global
From
Drug Discovery Informatics Market 2024-2028 - Product Image

Drug Discovery Informatics Market 2024-2028

  • Report
  • 167 Pages
  • Global
From

About the Drug Discovery Informatics Market

Drug Discovery Informatics is a field of research that focuses on the development of software and databases to support the drug discovery process. It involves the integration of data from multiple sources, such as biological, chemical, and clinical data, to enable the identification of potential drug targets and the development of new drugs. Drug Discovery Informatics also includes the development of algorithms and software tools to analyze and interpret data, as well as the development of predictive models to identify potential drug candidates. Drug Discovery Informatics is an important part of the drug discovery process, as it enables the efficient and effective analysis of large amounts of data. It also helps to reduce the cost and time associated with drug discovery, as well as to improve the accuracy of drug discovery. Some companies in the Drug Discovery Informatics market include IBM, Microsoft, Oracle, Infor, and Accenture. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.